Log In
Print this Print this

Recombinant Human ERBB3 fragment injection (rhErbB3-f)

  Manage Alerts
Collapse Summary General Information
Company Zensun (Shanghai) Sci. & Tech. Co. Ltd.
DescriptionRecombinant human ERBB3 fragment (rhErbB3-f) vaccine
Molecular Target Erb-b2 receptor tyrosine kinase 3 (ERBB3) (HER3) (EGFR3)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today